Clinical Trials Directory

Trials / Sponsors / Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc.

Industry · 10 registered clinical trials — 7 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingStudy of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL
B-cell Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 32026-06-01
Not Yet RecruitingStudy of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
B-cell Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 1 / Phase 22026-05-01
RecruitingA Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)
Phase 22025-10-15
RecruitingRelative Bioavailability of NX-5948 Tablets vs Capsules and the Effect of Covariates on the PK of NX-5948 Tabl
Healthy Volunteer
Phase 12024-11-30
CompletedAbsolute Bioavailability, Absorption, Metabolism, Excretion, and Mass Balance Study of [14C] NX-5948
Healthy Volunteer
Phase 12024-11-01
CompletedA Food-Effect, Drug-Drug Interaction, and Pharmacokinetics Study of NX-5948 in Healthy Adult Subjects
Healthy Volunteers
Phase 12024-08-20
RecruitingA Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL)
Phase 12022-04-13
TerminatedA Study of DeTIL-0255 in Adults With Advanced Malignancies
Platinum-resistant Ovarian Cancer, Endometrial Cancer, Cervical Cancer
Phase 12021-12-22
RecruitingA Study of NX-1607 in Adults With Advanced Malignancies
Ovarian Cancer, Epithelial, Gastric Cancer, GastroEsophageal Junction (GEJ) Cancer
Phase 12021-09-29
RecruitingA Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Waldenstrom Macroglobulinemia (WM)
Phase 12021-05-05